This site uses cookies to provide you with a more responsive and personalised service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Critical acclaim for The Strategy Paradox


“Raynor has taken the next giant leap forward in strategy. He demonstrates that much of what we know about creating value is true but woefully incomplete. By widening our focus from simply the pursuit of success to include ever-present uncertainty, Raynor does more than simply alert us to the long-ignored risk/return trade-off — he shows us how to break it.”

  — Jim Balsillie, co-CEO, Research In Motion (RIM)

“Very few executives or board members look forward to the annual corporate clairvoyant ritual known as strategic planning; in no small part because of the unspoken recognition that ‘our’ crystal ball’s vision of the future has no greater fidelity than the competition’s glass sphere. Since luck has rarely proved to be a sustainable business model, there exists a desperate need for a system to implement that can manage the unmanageable: How do you commit resources now to service customers and markets that will emerge in a distant and inherently unpredictable future? Just as Raynor succeeded in unlocking the mysteries behind innovation in The Innovator’s Solution, The Strategy Paradox provides an intelligent, robust practical compass that the nontelepathic can use to navigate through the inevitable course corrections that will be required along the journey to success. Drawing upon extensive data from business, probability, mathematical and behavioural sciences, and graphically illustrating his thesis with real-world examples of both successes and failures, Raynor beautifully explains how to create a portfolio of strategic options that will allow curative interventions as unforeseen circumstances and developments are inescapably encountered. In the business of healthcare, where product development timelines are measured over 10-15 years, but dramatic scientific advancements can radically change the playing field overnight, Raynor’s approach to strategic planning is not only the best manual on the subject written to date, it is an essential survival tool.”

  — William Hunter, MD, Founder, President & CEO, Angiotech Pharmaceuticals